Form 483

Element Research Group Inc. Form 483, 2026-06-26

FDA issued a Form 483 to Element Research Group Inc. on 2026-06-26 with 3 public-safe observations.

483· Form 483 issuedBiologics3 observations

Element Research Group Inc. · Brooklyn Park, United States · Issued June 26, 2026

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

26 Jun 2026
21 CFR 58.120(b)

Protocol: approval of changes

Cited by Yuanyuan Li

26 Jun 2026
21 CFR 58.33(b)

Study director: all data recorded and verified

Cited by Yuanyuan Li

26 Jun 2026
21 CFR 58.33(e)

Study director: follow GLP regulations

Cited by Yuanyuan Li

Inspected site

ERElement Research Group Inc.Brooklyn Park, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 58.120(b)Cited across public-safe Form 483 observations1x
21 CFR 58.33(b)Cited across public-safe Form 483 observations1x
21 CFR 58.33(e)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 3 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere